Drugs / 18F-FTX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05047913 | Sep 2021 → Feb 2027 expected | brain neoplasm, cervical cancer | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05047913 ↗ |
| Route | Intravenous | “Given By IV” NCT05047913 ↗ |